Dewmar International Reports 24% Sequential Revenue Growth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
101
Dewmar International Reports 24% Sequential Revenue Growth and Projects Almost $5 Million In Revenue for 2018

HOUSTON, TX--(Marketwired - Aug 21, 2017) -   Dewmar International BMC, Inc.  ( OTC PINK : DEWM ) is pleased to announce that it has achieved 24% sequential revenue growth for the period ended June 30, 2017 as compared to the period ended March 31, 2017. For the period ended June 30, 2017, Dewmar International reported revenues of $260,524 as compared to revenues of $210,215 for the period ended March 31, 2017.

During the second quarter of 2017, Dewmar experienced a one-time six figure expense related to the application process for medical marijuana licensure in Louisiana. Also, during this period the company also incurred a one-time six figure expense related to the re-launch of Willie's Duck Diner . Without these two major expenses, Dewmar International would have been profitable for the quarter.

For full year 2018, Dewmar International projects revenue of almost $5 million. According to the economic development coordinator for the City of West Monroe, the industry averages for restaurants the size of Willie's Duck Diner within the "restaurant row" corridor just off the Monroe area Interstate 20 is approximately $4 million annually. The Company anticipates achieving this number primarily due to an influx of tourists who plan to visit the new Duck Commander the Experience exhibit located at the Duck Commander headquarters less than a mile away from the diner which is expected to bring in approximately 800 bus visits annually via the Louisiana Association of Convention & Visitors Bureaus .

Additionally, for 2018, Dewmar is expecting continued growth from the Kush Cakes brand, healthcare services and hemp products. The company is also expecting continued growth in Lean with additional placement in Walmart stores in the Spring of 2018 which is the topic of discussion on an upcoming call on September 5th with the new Walmart Beverage Buyer. In 2018, revenues from the company's entertainment assets will begin to contribute to overall revenues with continued growth and accelerated growth from entertainment assets through 2020.

"I believe $5 million in 2018 annual revenue to be a conservative projection for Dewmar based upon the multiple business ventures we've established that are currently producing measurable revenue streams," says Dr. Marco Moran , CEO of Dewmar International. "In fact, these projections don't take into account the possible contributions from future planned acquisitions or the inclusion of any new medical marijuana licenses or permits that we are attempting to receive this year for implementation in 2018," Dr. Moran concluded.

About Dewmar International BMC, Inc. Dewmar International BMC, Inc. is a certified service-disabled veteran business concern, new product development, manufacturing and brand management company. Established in 2003, Dewmar's primary business strategy has been in creating high profit margins with functional nutritional supplements, such as Lean Slow Motion Potion™ , whose flavors include Yella, Purp and Easta Pink, is rated as one of the top 3 national selling relaxation drinks in the U.S. market and Kush Cakes relaxation brownies. The company has offices in Clinton, MS; Houston, TX; Denver, CO and New Orleans, LA. Dewmar was rated by the Mississippi Business Journal in 2015 as one of the State's top 15 publicly traded companies.

Follow Dewmar on its official Facebook and Twitter sites where the CEO is inclined to provide information, sometimes on a daily basis, about some of the Company's current activities and key staff activities. Also, subscribe to our Company Newsletter on the bottom right of our homepage on our website to receive updates as well.

This press release may contain forward-looking statements within the meaning of section 27-A of the Securities Act of 1933 as amended and section 21-E of the Securities and Exchange Act of 1934 as amended. Such forward-looking statements include, but are not limited to, statements regarding Dewmar's financial position and business prospects including details on timing, product distribution, FDA regulation, financing, and market acceptance of products and statements predicting trends of sales and market conditions and opportunities in the markets in which Dewmar sells its products and services.

Such statements involve risks and uncertainties and actual results could differ materially from the results anticipated in such forward-looking statements as a result of a number of factors including, but not limited to, the risk that the manufacturing of Dewmar's products or services may be delayed or may not be rolled out as predicted due to technological, market or financial factors including the availability of necessary working capital, the risk that the market acceptance and sales opportunities may not happen as anticipated. Dewmar does not undertake any obligation to update any such forward-looking statements.

Dewmar International BMC, Inc. Investment & Company Information InvestorRelations@DewmarInternational.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 88

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 7

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 19

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 42

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 114

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 91

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 136

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading

Top 5 Most Recently Viewed Articles

Moatable, Inc. Concludes the Tender Offer for Class A Shares

Updated Category News Views 139

Moatable, Inc. Completes Tender Offer for Class A Shares Moatable, Inc. (Pink Limited Market: MTBLY), a premier US-based SaaS company, has announced the successful completion of its fixed price tender offer. The company aimed to repurchase an impressive 225 million Class A ordinary shares. Each share has a par value of $0.001, and they can also be represented by American...

Continue Reading
Armstrong World Industries' Q4 Earnings: What Investors Need

Updated Category News Views 164

Armstrong World Industries Q4 Earnings Report Let’s dive right into this latest earnings report from Armstrong World Indus (NYSE:AWI) that just hit the streets. Released on February 24, 2026, bright and early, it’s got both good news and some not-so-great tidbits that every investor should chew on. Honestly, missing earnings estimates by a margin like -3.59% just...

Continue Reading
Batteries Plus Enhances Partnership for Educational Safety Needs

Updated Category News Views 254

Batteries Plus Enhances Partnership for Educational Safety Needs From Campus Fleets to Classroom Security, Local Teams Support Operational Readiness for Schools and Universities Nationwide Batteries Plus is deepening its partnerships with K-12 districts, colleges, and universities by supplying a broad range of comprehensive battery, lighting, and security system support....

Continue Reading
Exciting Developments in Houston: The RO Project Advances

Updated Category News Views 453

Transwestern Launches Next Phase of The RO Development Transwestern, a prominent commercial real estate firm headquartered in Houston, has taken a monumental step forward by breaking ground on the next phase of The RO. This innovative project aims to redefine the River Oaks neighborhood, representing a significant addition to the area that harmonizes various aspects of...

Continue Reading
BMO Financial Group Plans Large Share Repurchase Initiative

Updated Category News Views 95

BMO Financial Group's Strategic Share Buyback Program Bank of Montreal (TSX:BMO)(NYSE:BMO) has announced an ambitious plan to repurchase up to 20 million common shares through a normal course issuer bid. This initiative is designed to strengthen the bank's capital structure and reflects its confidence in its business fundamentals. Details of the Share Repurchase Plan The...

Continue Reading